SSX7 Antikörper (Middle Region)

Produktnummer ABIN2784590

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch SSX7 in WB. Er zeigt eine Reaktivität gegenüber Human.

Kurzübersicht für SSX7 Antikörper (Middle Region) (ABIN2784590)

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX7 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-SSX7 Antikörper

Bindungsspezifität: Middle Region

Sequenz: IFPKIMPKKP AEEGNDSKGV PEASGSQNDG KHLCPPGKPS TSEKINKTSG

Homologie: Human: 100%

Produktmerkmale: This is a rabbit polyclonal antibody against SSX7. It was validated on Western Blot using a cell lysate as a positive control.

Aufreinigung: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human SSX7

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator.

Kommentare:

Antigen size: 188 AA

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Details zu SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Andere Bezeichnung: SSX7

Hintergrund: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.
Protein Size: 188

Molekulargewicht: 21 kDa

Gen-ID: 280658

NCBI Accession: NM_173358, NP_775494

UniProt: Q7RTT5